Maxhaler, an innovative multi-dose Dry Powder Inhaler by Beximco Pharmaceuticals Ltd., gained an Honorable Mention at the Bangladesh Business Innovation Award (BBIA) 2019 under the ‘Best Innovation – Healthcare’ category. The following is the story of how they achieved this feat.
The burden of respiratory diseases such as asthma and COPD is rising alarmingly in Bangladesh. Against this backdrop, Beximco focused on a breakthrough in the inhalation segment. The inhalers are first-line therapy in the treatment of Asthma-COPD. Despite effective therapy with current capsule-based DPI, many patients found this inhalation process inconvenient, difficult to follow which results in wasting of 30-60% dose without any benefit to the patients. Beximco listened to their doctors, patients and their need for a simple, easy-to-use and convenient device.
As a result of this, the Maxhaler was developed. It is a multi-dose Dry Powder Inhaler (mDPI) incorporating sophisticated technology that contains the dosages required by a patient during a period of one month (30 calendar days). This is a pre-dispensed, only 3 easy steps to use device offers improved adherence for better control of asthma and COPD.
To introduce this technology in Bangladesh for the first time, Beximco’s scientists in R&D worked for years in collaboration with global consultants, scientists, and engineers for ensuring inhalation powder best in fitted for the Device for accurate and consistent delivery. There are only a handful of manufacturers globally who have successfully introduced this delivery system, given the complexity of this product in terms of patents and technical know-how.
During the whole journey of breakthrough innovation, the company always tries to keep their company vision alive which is providing affordable medicine to their patients and now more patients have access to their multi-dose Dry Powder Inhaler i.e. MAXHALER. Being the largest exporter of Inhalers in Bangladesh, we believe through MAXHALER, we will take Bangladeshi medicines to the world in a big way.